.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Baxter
McKesson
US Department of Justice
Johnson and Johnson
Express Scripts
Medtronic
Deloitte
AstraZeneca

Generated: September 20, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: verteporfin

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119NDAValeant Pharmaceuticals North America LLC0187-5600-151 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0187-5600-15)
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119NDAQLT Ophthalmics, Inc.50236-001-151 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (50236-001-15)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Queensland Health
Harvard Business School
Cantor Fitzgerald
Cerilliant
Covington
Teva
Chubb
Federal Trade Commission
Daiichi Sankyo

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot